GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Cash-to-Debt

PharmaRoth Labs (PharmaRoth Labs) Cash-to-Debt : N/A (As of Mar. 2011)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. PharmaRoth Labs's cash to debt ratio for the quarter that ended in Mar. 2011 was N/A.

The historical rank and industry rank for PharmaRoth Labs's Cash-to-Debt or its related term are showing as below:

ROTH's Cash-to-Debt is not ranked *
in the Biotechnology industry.
Industry Median: 6.49
* Ranked among companies with meaningful Cash-to-Debt only.

PharmaRoth Labs Cash-to-Debt Historical Data

The historical data trend for PharmaRoth Labs's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

PharmaRoth Labs Cash-to-Debt Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
Cash-to-Debt
N/A N/A -

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A - N/A - N/A

Competitive Comparison of PharmaRoth Labs's Cash-to-Debt

For the Biotechnology subindustry, PharmaRoth Labs's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaRoth Labs's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaRoth Labs's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where PharmaRoth Labs's Cash-to-Debt falls into.



PharmaRoth Labs Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

PharmaRoth Labs's Cash to Debt Ratio for the fiscal year that ended in Jun. 2010 is calculated as:

PharmaRoth Labs's Cash to Debt Ratio for the quarter that ended in Mar. 2011 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaRoth Labs  (GREY:ROTH) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


PharmaRoth Labs Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines